c Soluble cyanobacterial granule polypeptide (CGP), especially that isolated from recombinant Escherichia coli strains, consists of aspartic acid, arginine, and a greater amount of lysine than that in insoluble CGP isolated from cyanobacteria or various other recombinant bacteria. In vitro guanidination of lysine side chains of soluble CGP with o-methylisourea (OMIU) yielded the nonproteinogenic amino acid homoarginine. The modified soluble CGP consisted of 51 mol% aspartate, 14 mol% arginine, and 35 mol% homoarginine. The complete conversion of lysine residues to homoarginine was confirmed by (i) nuclear magnetic resonance spectrometry, (ii) coupled liquid chromatography-mass spectrometry, and (iii) high-performance liquid chromatography. Unlike soluble CGP, this new homoarginine-containing polyamide was soluble only under acidic or alkaline conditions and was insoluble in water or at a neutral pH. Thus, it showed solubility behavior similar to that of the natural insoluble polymer isolated from cyanobacteria, consisting of aspartic acid and arginine only. Polyacrylamide gel electrophoresis revealed similar degrees of polymerization of the native (12-to 40-kDa) and modified (10-to 35-kDa) polymers. This study showed that the chemical structure and properties of a biopolymer could be changed by in vitro introduction of a new functional group after biosynthesis of the native polymer. In addition, the modified CGP could be digested in vitro using the cyanophycinase from Pseudomonas alcaligenes strain DIP1, yielding a new dipeptide consisting of aspartate and homoarginine.
C
yanophycin, a nitrogen and energy storage compound, originates from cyanobacterial cells and consists of a polyaspartic backbone to which arginine residues are linked by isopeptide bonds at free carboxylate groups (1, 2) . The polymer is also designated multi-L-arginyl-polyaspartic acid, or cyanobacterial granule polypeptide (CGP) (1, 2) . The nonribosomal synthesis of CGP depends on the cyanophycin synthetase CphA, encoded by the cphA gene, and requires ATP, MgCl 2 , KCl, and a sulfhydryl reagent, such as ␤-mercaptoethanol or dithiothreitol (3) . The molecular mass of this synthesized polydisperse copolymer ranges from about 25 to 100 kDa (4); it is insoluble at physiological pH but soluble under acidic or alkaline conditions (5) .
From recombinant microorganisms, such as yeasts or bacteria expressing different cphA genes from cyanobacteria or noncyanobacteria, a CGP-derived water-soluble polymer can also be isolated (6) (7) (8) (9) . Soluble CGP differs from insoluble CGP with regard to amino acid composition and molecular mass distribution, which are dependent on the origin of CphA (9) . In soluble CGP, 16 to 25 mol% arginine residues are replaced by ornithine, citrulline, or lysine residues, and the molecular masses range from 17 to 30 kDa, 14 to 66 kDa, or 12 to 40 kDa, respectively (7, 9, 10) .
The abundant polymers cellulose (poly-␤-1,4-D-glucopyranose) and chitin (poly-␤-1,4-N-acetyl-D-glucosamine) share a property with CGP. These polymers are water insoluble, but in each case, a derived polymer is soluble in water (7, 9, 10, 11, 12) . The substituent groups of modified celluloses, such as ethyl and carboxymethyl derivatives and methyl cellulose, disrupt the hydrogen bonding, and the resulting compounds become more soluble (11) . During the carboxymethylation of chitin, the hydroxyl group is substituted by a carboxymethyl group (13) , the hydrogen bonds are disrupted by the hydrophobic methyl group, and solubility is enhanced by the carboxyl group (14) .
Arginine side chains often play a previously unappreciated general structural role in the maintenance of tertiary structure in proteins, and the positively charged planar guanidino groups may be hydrogen donors in the formation of as many as 5 hydrogen bonds (15) . Therefore, a substitution of functional ε-amino groups of soluble CGP by guanidino groups not only will change the structure of the polymer but should also change its solubility behavior.
A method for modification of functional ε-amino groups is guanidination using o-methylisourea (OMIU) (16) . Lysine residues are transformed to homoarginine (2-amino-6-guanidinohexanoic acid) by reaction with OMIU under alkaline conditions (17) . This procedure has been used to modify enzymes (18) (19) (20) (21) or biologically active proteins (22) (23) (24) Furthermore, guanidination of dietary proteins has been used to measure losses of endogenous amino acids in poultry (25) (26) (27) , growing pigs (28) (29) (30) , or rats (30, 31) . In the same way, guanidination of lysine in proteins seems to be useful for improved detection and sequencing of tryptic digested peptides during liquid chromatography (LC)-matrix-assisted laser desorption ionization mass spectrometry (MALDI-MS) (32, 33) , in proteomics (34) , and for global characterization of peptide mixtures by MALDI-MS (35) .
Cyanophycin and derived polymers are used as the starting material for the production of nitrogen-containing bulk chemicals and also as the source for a polyaspartic-acid-like polymer with reduced arginine content that may find applications in different areas (36, 37) . Furthermore, treatment of CGP with cyano-phycinase (CGPase) yields ␤-dipeptides consisting of ␤-aspartate-arginine and ␤-aspartate-lysine (38) . The use of CGP and/or its dipeptides is an ideal approach for oral administration of the constituting amino acids as therapeutics and/or nutritional agents (39) .
This study was done to demonstrate that a particular watersoluble and lysine-rich form of CGP has potential for the synthesis of a new polymer in vitro. Lysine residues of this polydisperse polymer are converted to homoarginine in a chemical process using OMIU under alkaline conditions. The resulting polymer consists of 51 mol% aspartic acid, 14 mol% arginine, and 35 mol% homoarginine. The composition was confirmed by high-performance liquid chromatography (HPLC) and could be additionally verified with nuclear magnetic resonance (NMR) and mass spectrometry (MS) measurements. The new polymer has a solubility behavior different from that of the initial polymer. In addition, ␤-dipeptides consisting of ␤-aspartate-homoarginine and ␤-aspartate-arginine were obtained by treatment of the modified CGP (mCGP) with CGPase. This new dipeptide expands the spectrum of available dipeptides and could be interesting for medical applications.
MATERIALS AND METHODS

Source of CGP.
To obtain large amounts of soluble CGP, freeze-dried CGP-containing cells of Escherichia coli HMS174(DE3) ⌬dapE ⍀Amp r pCOLADuet-1::cphA C595S ::dapL Ss (40) were used. These cells were previously produced by cultivation on a 25-liter scale in a Biostat UD30 stainless steel bioreactor (B. Braun Biotech International, Melsungen, Germany). Cultivation was carried out at 30°C for 24 h using terrific broth (TB) medium and ␣-lactose for induction. The pH in the medium was kept between 6.8 and 7.0 by controlled addition of 4 N HCl or NH 4 OH (25%, wt/vol). During the fermentation, oxygen (O 2 ), pH, foam, temperature, and optical density at 850 nm were measured, while process control and data processing were carried out by a digital control unit in combination with the MFCS/win software package (B. Braun Biotech International).
Harvesting of cells from 25-liter-scale cultivations. Cells were harvested by centrifugation at 4°C in a CEPA type Z41 or type Z61 continuous centrifuge (Carl Padberg Zentrifugenbau GmbH, Lahr, Germany). The harvested cells were lyophilized using a Beta 1-16 freeze dryer (Christ, Osterode, Germany), and the cell mass was gravimetrically determined.
Isolation of CGP. The CGP-containing freeze-dried cells were diluted in H 2 O (1 g in 10 ml) (41), adjusted to pH Ͻ1.5 by the addition of concentrated HCl, and stirred at 4°C overnight. The solution was centrifuged for 30 min (at 4°C and 9,000 ϫ g); the CGP-containing supernatant was neutralized (pH 7.0) with NaOH; and insoluble CGP was precipitated. The turbid suspension was left to settle overnight at 4°C (38) and was again centrifuged (at 4°C for 30 min at 9,000 ϫ g). The clear supernatant was then treated by adding 2 volumes of ice-cold 96% (vol/vol) ethanol. Once again, the precipitate was left to settle overnight at 4°C and was collected by a centrifugation step and a subsequent washing step with acetone (42) . The precipitate was dissolved in 20 mM Tris-HCl (pH 7.5), and the sample was repeatedly precipitated with ethanol and washed with acetone; finally, the polymer was dried in vacuo (Vacutherm; Heraeus).
Guanidination of CGP. CGP samples were treated according to the protocol for guanidination of proteins (17) . The samples were dissolved in a fresh 0.4 M OMIU solution adjusted with NaOH to pH 10.5. Samples were incubated at room temperature (RT) for 24 h (17) or at 65°C for 5 to 10 min (43) . After treatment of CGP with OMIU, minor amounts of precipitates were removed by centrifugation (4,000 rpm, 15 min, RT). Guanidinated CGP samples were isolated after several steps. CGP was precipitated at pH 3 with 4 M HCl and was subsequently washed with water at pH 3 (17) . Afterward, the guanidinated CGP samples were dried.
PAGE.
Sodium dodecyl sulfate-polyacrylamide electrophoresis (SDS-PAGE) was performed in 11.5% (wt/vol) polyacrylamide gels as described by Laemmli (44) to analyze soluble CGP and guanidinated CGP. A 3-foldconcentrated denaturation buffer consisting of ␤-mercaptoethanol, glycerol, SDS, and bromophenol blue was used for sample preparation. Prestained molecular mass markers from Fermentas (a three-color ladder with 10 recombinant prokaryotic proteins covering a molecular mass range from 10 to 170 kDa) were used for the determination of molecular masses. Proteins were stained with Serva Blue R.
HPLC for amino acid analysis. The amino acid constituents of isolated CGP were determined by high-performance liquid chromatography (HPLC) by using a Waters B801 column (300 by 4 mm) as described by Aboulmagd et al. (45) and Steinle et al. (10) . Precolumn ortho-phthaldialdehyde (OPA) derivatization was carried out in a Smartline autosampler, model 3900, as depicted in the manual (Knauer GmbH, Berlin, Germany). Calibration was done with a mixture consisting of 1.25 mM aspartate, 1.25 mM arginine, and 1.25 mM lysine in HPLC buffer. This mixture was further diluted until a concentration of 0.156 mM each amino acid was reached. L-Homoarginine was purchased as the monochloride from Alfa Aesar.
NMR. 1 H nuclear magnetic resonance (NMR) measurements were performed with a 600-MHz Agilent DD2 spectrometer (1D 1 H; 599.8 MHz). A relaxation delay of 1 s and an acquisition time of 4 s were used. The number of scans was 128. Samples of 10 mg were previously hydrolyzed with 6 N HCl at 95°C for 18 h and were subsequently lyophilized. The freeze-dried samples were solubilized with deuterium oxide (D 2 O) (Carl Roth GmbH, Germany).
LC-MS.
For qualitative analysis of one amino acid from a mixture by mass spectrometry (MS), the constituents were first separated by LC, using the HPLC system and method described above, with 50 mM ammonium acetate containing 40% methanol (pH 7.5) as the eluent (10) . The fraction containing the separated amino acid was collected and acidified with 15% (wt/vol) trichloroacetic acid prior to injection into the MS apparatus (LXQ MS detector; Thermo Fisher Scientific). The samples were injected at a maximal flow rate of 63 l per min with a 500-l syringe (Hamilton). The MS was operated in the electron spray ionization (ESI) mode using positive polarity. Scanning was performed at 50 to 1,000 Da.
Digestion of CGP samples with cyanophycinase. Exactly 10 mg of soluble CGP and 10 mg of guanidinated CGP were resuspended in 900 l of 20 mM Tris-HCl (pH 8.0). In this solution, 100 l of crude CphE al , isolated from a culture supernatant of Pseudomonas alcaligenes DIP1, was added to each sample as described previously by Sallam et al. (38) . The samples were incubated at 50°C in a heating block overnight (12 to 15 h). The dipeptides were concentrated and isolated using ultrafiltration units (Sartorius) with a molecular weight cutoff (MWCO) of 3,000. The dipeptides with molecular masses of around 300 Da were collected in the flowthrough and were further analyzed by HPLC.
RESULTS
Large-scale isolation of soluble CGP. In this study, a recombinant E. coli strain provided with a plasmid addiction system encoding the engineered cyanophycin synthetase CphA C595S , exhibiting enhanced enzyme activity (40) , was cultivated on a 25-liter scale. For the first time, insoluble CGP and soluble CGP were isolated from this strain, cultivated in complex TB medium supplemented with ␣-lactose as an additional carbon source and inductor for the vector system. Frommeyer and Steinbüchel (9) showed that in soluble CGP from recombinant E. coli expressing cphA from Synechocystis sp. strain PCC 6308 (cphA 6308 ), as much as 25 mol% lysine was incorporated. Similar results regarding molecular mass and amino acid composition were observed in this study, as detailed below.
Guanidination of soluble CGP. The molar composition of soluble CGP isolated from E. coli HMS174(DE3) ⌬dapE ⍀Amp r pCOLADuet-1::cphA C595S ::dapL Ss was analyzed by HPLC. A composition of, on average, 51 mol% aspartic acid, 14 mol% arginine, and 35 mol% lysine was detected. A lysine content of more than 30 mol% was never reported before for CGP. This soluble and lysinerich polymer was used for guanidination experiments under different conditions. For guanidination (Fig. 1 ) of soluble CGP, a 0.4 M OMIU solution adjusted to pH 10.5 with NaOH was used (17). Imbeah et al. (17) reported the precipitation of casein at pH 3 with 4 M HCl after treatment with OMIU. Guanidinated CGP samples were not precipitated at pH 3 with 4 M HCl. In contrast, precipitation of guanidinated CGPs, irrespective of the conditions used, was detected after treatment with acidified ethanol. Furthermore, precipitates were dissolved with 0.1 N HCl after a centrifugation step (10 min, 4,000 rpm, RT). Samples precipitated again with NaOH alkalized ethanol. Precipitates were harvested by a centrifugation step (10 min, 4,000 rpm, RT) and were washed with water. Afterward, the guanidinated CGP samples were dried.
In contrast to the native polymer, the substances formed were not water soluble, and about 25 to 35% (wt/wt) of the mCGP could be recovered. Since the native polymer was water soluble, a conversion of lysine residues to homoarginine was assumed.
Determination of amino acid composition of guanidinated samples by HPLC. The amino acid compositions of soluble CGP and guanidinated samples were determined and compared by HPLC (Fig. 2 ). For precise separation of the peaks, a 60-min HPLC program was applied. As mentioned above, soluble CGP isolated from E. coli HMS174(DE3) ⌬dapE ⍀Amp r pCOLADuet-1::cphA C595S ::dapL Ss was composed of, on average, 51 mol% aspartic acid, 14 mol% arginine, and 35 mol% lysine. In contrast, no lysine could be detected in the guanidinated samples. In addition to the aspartic acid and arginine peaks, a new third peak was detected by HPLC (Fig. 2B) . A clear difference between the composition of soluble CGP and that of the guanidinated sample was visible, confirming that the lysine side chain was probably converted to homoarginine. The complete guanidination of lysine residues was confirmed with purchased homoarginine hydrochloride and by different analytic methods. The retention time of the pure substance correlated with the retention time of the third peak of the guanidinated CGP analyzed by HPLC (Fig. 2B and C) . Therefore, the HPLC diagram of the guanidinated samples after 60 min showed improved separation of three peaks representing aspartic acid, arginine, and homoarginine (Fig. 2B ). This was a further hint that the guanidination of soluble CGP was successful and that a new polymer was obtained.
Determination of guanidination of soluble CGP by different analytical methods. Additional analyses of the new polymer were needed, because until now, neither an in vitro-synthesized CGPderived polymer with homoarginine as a constituent nor an in vivo-synthesized CGP containing homoarginine was known. For this purpose, the guanidinated polymer was subjected to 1 H NMR measurements were carried out for qualitative and quantitative analyses of soluble CGP and mCGP (Fig. 3) . For this purpose, the samples were treated with 6 N HCl for 18 h at 95°C. On the one hand, the conversion of lysine to homoarginine, providing the structural difference between mCGP and soluble CGP, could be definitely confirmed by the assignment of signals of hydrogen atoms to relative carbon atoms. On the other hand, a molar ratio of 53 mol% aspartate, 14 mol% arginine, and 33 mol% lysine for soluble CGP, in contrast to 32 mol% homoarginine for mCGP, was determined; these results resembled those of HPLC measurements. The molar contents of lysine and homoarginine also indicated an almost complete and practically equimolar conversion.
Qualitative proof for the presence of homoarginine was also obtained by the application of ESI to a certain fraction obtained after separation of the hydrolyzed polymer by HPLC. Homoarginine, with an m/z value of 305.24 (HomArg-OPA ϩ H 2 O), was detected in guanidinated CGP, and the m/z value obtained corresponded to the calculated mass of the fragment (Fig. 4) . For confirmation of this result, a homoarginine standard was also analyzed by ESI of the previously derivatized sample. An m/z value of 305.2 was also detected for the standard, confirming the previously determined result (Fig. 4 ). After HPLC, 1 H NMR, and MS analyses of soluble CGP and mCGP, their molecular structures were proposed (Fig. 5) .
Analysis of guanidinated samples by SDS-PAGE.
To investigate whether the treatments of soluble CGP with OMIU described above had an influence on the molecular mass distributions, soluble CGP and the guanidinated samples were analyzed by SDS-PAGE. For this purpose, 80 g of soluble CGP and 80 g of gua- ( Fig. 6) . Therefore, all guanidinated samples showed molecular masses slightly lower than that of soluble CGP. Determination of the solubility behavior of mCGP. Soluble CGP isolated from recombinant bacteria is soluble in water in a range from pH 1.0 to pH 14.0. Precipitation and isolation of this polymer are possible by employing ethanol (7) (8) (9) 43) . The solubility behavior of mCGP was also characterized in a range from pH 1.0 to 14.0. mCGP was solubilized in 0.1 N HCl and was stirred continuously during the addition of NaOH drop by drop. The polymer was precipitated from pH 4.0 to pH 8.0 and disappeared under more alkaline conditions. The conclusion from this analysis is that the guanidination of the lysine-rich CGP converted the water-soluble polymer into a non-watersoluble polymer. Therefore, the exchange of a functional group not only changed the structure but also influenced the solubility of the cyanophycin.
Degradation of soluble CGP and mCGP to their dipeptides. After confirmation of the successful guanidination of soluble CGP by different analytical methods, the synthesis of dipeptides originating from this new polymer was considered. mCGP could be a suitable source for a new dipeptide. Therefore, samples of soluble CGP and mCGP were incubated in 20 mM Tris-HCl (8.0) at 50°C for several hours with CGPase, which was isolated from the culture supernatant of Pseudomonas alcaligenes DIP1 cells. The nonwater-soluble mCGP suspension was turbid before treatment with CGPase. During incubation with CGPase, the suspension became clearer, providing the first evidence for digestion of mCGP containing homoarginine by CGPase. In contrast, the water-soluble CGP solution was clear before and after treatment with CGPase. Further analysis of the dipeptides obtained from digested mCGP and soluble CGP was needed for confirmation of successful digestion. Dipeptides could be detected by HPLC. ␤-Aspartate-arginine and ␤-aspartate-lysine dipeptides (Fig. 7) were detected by HPLC for soluble CGP treated with CGPase, whereas ␤-aspartate-arginine and ␤-aspartate-homoarginine dipeptides (Fig. 7) were detected by HPLC for mCGP after digestion with CGPase. ␤-Aspartate-homoarginine dipeptides have never been isolated before and are therefore a novelty. The conclusions from these results are that the cyanophycinase used is even less specific than reported before (38) and that guanidination of soluble CGP extends the range of dipeptides that can be obtained by biological processes. 
DISCUSSION
In this study, we demonstrated the chemical conversion of the amino acid lysine of the bacterial polyamide cyanophycin and thereby the conversion of the water-soluble polymer to an insoluble polymer. Guanidination of lysyl residues under alkaline conditions can modify a protein's structure in vitro by conversion of a functional ε-amino group to the functional guanidino group. The result is a derivative of arginine/lysine designated homoarginine, an amino acid with a molecular mass of 188 Da. The conversion of lysine to homoarginine by treatment with OMIU was performed on various proteins as described previously (17) (18) (19) (20) (21) (22) (23) (24) , but never on CGP. Until now, only insoluble CGP has been isolated from different recombinant bacterial strains cultivated on a technical scale (38, 40, 41, 45, 46) . For this study, a lysine-rich derivative of CGP was isolated from a strain exhibiting an addiction system with a mutated cphA 6308 (40) . Previous cultivations of this strain in mineral salt medium at 30°C on a 30-liter scale resulted only in insoluble CGP with a lysine content of nearly 6 mol% (40). Soluble CGPs with increased lysine contents have been isolated from several recombinant E. coli strains expressing different cphA genes and have been cultivated at 30°C in TB medium (9) . Therefore, the strain exhibiting an addiction system with a mutated cphA 6308 was cultivated in complex TB medium at 30°C on a 30-liter scale, and soluble CGP was formed to a certain extent and was subsequently isolated and purified. A lysine content as high as 35 mol%, on average, in soluble CGP was never reported before and must be the result of the cultivation conditions chosen and the DapE-DapL plasmid-dependent addiction system with mutated cphA inserted.
There are different protocols for guanidination of proteins depending on the application. On the one hand, enzymes or bioactive proteins have been guanidinated on a small scale for functional analysis, and on the other hand, nutrient proteins, such as casein or soybean meal, have been guanidinated on a large scale for feeding studies with different animals (17) . Therefore, it was demonstrated that the lysyl residues of soluble lysine-rich CGP could be converted by using three different conditions. In contrast to casein, guanidinated CGP was precipitated by acidified ethanol. The different conditions for precipitation might be due to the different lysine contents of the two polypeptides. In contrast to soluble CGP, casein contains merely 7.5 mol% lysine (47) .
The three differently treated samples and soluble CGP were analyzed by HPLC and SDS-PAGE. No lysine was detected in any of the guanidinated samples, but a peak representative of homoarginine was detected in each case. The sample incubated for 5 min at 65°C was further analyzed as a representative polymer by 1 H NMR and LC-MS. Therefore, the composition and conversion :dapL Ss and consisting of 51 mol% aspartate, 14 mol% arginine, and 35 mol% lysine, and mCGP, originating from soluble CGP treated with OMIU under alkaline conditions, were treated with CGPase for several hours at 50°C. Cyanophycinase was previously isolated from a supernatant of P. alcaligenes DIP1. Ten milligrams of each sample was resuspended in 900 l 20 mM Tris-HCl (pH 8.0), and 100 l of concentrated CGPase was added. Dipeptides were concentrated and isolated using ultrafiltration units (Sartorius) with a molecular weight cutoff of 3,000. The chemical structures of the resulting dipeptides are given.
of all lysine residues were confirmed by these methods and were assigned to the other samples due to the identical results obtained by HPLC.
No striking difference in the molecular masses of the modified samples was revealed. However, the treatment for 5 to 10 min at 65°C or for 24 h at room temperature had a slight effect on the molecular mass in comparison to that of soluble CGP. The molecular mass of modified samples ranged from approximately 10 to 35 kDa, whereas the molecular mass range of soluble CGP was slightly higher. It was expected that mCGP had a higher molecular mass due to the higher molecular mass of homoarginine than of lysine. Therefore, treatment with OMIU must have a certain effect on the chain length of CGP, slightly reducing the molecular mass range of mCGP.
Another, more striking difference was detected with regard to solubility behavior. The native polymer was soluble in water and could not be precipitated by neutralization. In contrast, the modified polymers were soluble in 0.1 N HCl and could be precipitated using NaOH in a range from pH 4.0 to pH 8.0. The insoluble CGP isolated from cyanobacteria or recombinant bacteria expressing cphA exhibited similar solubility behaviors. The only difference between the structures of the two polymers is the replacement of lysine with the amino acid homoarginine. Insoluble CGP isolated from recombinant E. coli expressing cphA 6308 has a molecular mass ranging from approximately 25 to 35 kDa. Therefore, another conclusion of this study is that only the functional groups of the side chains connected to the polyaspartic backbone of CGP by isopeptide bonds play an important role in determining solubility.
Sallam et al. (38, 39) discussed the fact that cyanophycin-derived dipeptides and synthetic oligomer combinations of amino acids have been proven to have higher bioavailability than free amino acids and have often been investigated and applied in nutrition and therapy. It was also reported that any alteration in CGP structure would increase the range of CGP dipeptides and consequently extend their potential applications as therapeutics and/or nutritional supplements.
For the first time, this study demonstrated that CGPase from P. alcaligenes DIP digested the in vivo-synthesized soluble CGP, consisting, on average, of 51 mol% aspartate, 14 mol% arginine, and 35 mol% lysine, as well as the in vitro-synthesized and characterized insoluble mCGP, into dipeptides. Whether a polymer derived from chemically modified CGP could be digested by CGPase had never been tested before.
In several studies, during the past 3 years, it was assumed that there is a correlation between low homoarginine concentrations and different diseases, such as cardiovascular diseases or sudden cardiac death (48) (49) (50) , high bone turnover of female patients (51), or kidney failure (52) . Therefore, investigation of the application of cyanophycin-derived dipeptides as therapeutics, mCGP as a source for new dipeptides consisting of aspartate and homoarginine, and the different diseases related to low homoarginine concentrations could be interesting for the therapy of these diseases.
In conclusion, lysine-rich cyanophycin isolated from recombinant bacteria has never been guanidinated before. The complete conversion of available functional amino groups to functional guanidino groups of lysl residues was accomplished in 5 min at 65°C under alkaline conditions. The result is a new polydisperse copolymer consisting of a polyaspartic acid backbone to which arginine and homoarginine residues are linked by isopeptide bonds to the second carboxylate groups. This polymer is equivalent to insoluble CGP with regard to pH-dependent solubility behavior. Therefore, the results obtained in this study support the hypothesis that the different solubility behaviors of cyanophycin depend only on the occurrence of certain functional groups. Moreover, this in vitro-synthesized polymer is biodegradable due to the fact that dipeptides consisting of aspartate-arginine and aspartate-homoarginine could be detected after treatment with CGPase.
